Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant Calmegin antibody

KD Validated CLGN Reactivity: Human, Mouse, Rat WB, IHC, IP, ICC, IF Host: Rabbit Monoclonal unconjugated Recombinant Antibody
Catalog No. ABIN7606800
  • Target See all Calmegin (CLGN) Antibodies
    Calmegin (CLGN)
    Antibody Type
    Recombinant Antibody
    Reactivity
    • 31
    • 8
    • 8
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    Human, Mouse, Rat
    Host
    • 23
    • 9
    Rabbit
    Clonality
    • 17
    • 15
    Monoclonal
    Conjugate
    • 21
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This Calmegin antibody is un-conjugated
    Application
    • 20
    • 12
    • 11
    • 7
    • 6
    • 5
    • 4
    • 2
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC), Immunofluorescence (IF)
    Purpose
    Calmegin Rabbit mAb
    Specificity
    Calmegin Antibody detects endogenous levels of total Calmegin
    Purification
    Affinity-chromatography
    Grade
    KD Validated
    Immunogen
    A synthesized peptide derived from human Calmegin
    Isotype
    IgG
    Top Product
    Discover our top product CLGN Primary Antibody
  • Application Notes
    WB: 1:5000~1:10000 IHC: 1:50~1:200 ICC/IF: 1:50~1:100 IP: 1:20
    Restrictions
    For Research Use only
  • Buffer
    phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-20 °C
    Storage Comment
    Store at +4°C short term. Store at -20°C long term. Avoid freeze / thaw cycle.
  • Target
    Calmegin (CLGN)
    Alternative Name
    Calmegin (CLGN Products)
    Background
    CLGN, MEG 1 antigen, Calnexin-T, Calmegin precursor, Calmegin,
    Molecular Weight
    100kDa
    UniProt
    O14967
You are here:
Chat with us!